Potential association between frailty and pTau in community-dwelling older adults

Background Frailty is a geriatric syndrome characterized by a decline in physiological reserves, and multiple factors contribute to the occurrence and development of frailty. Growing evidence supports a strong link and overlap between frailty and cognitive impairment, but the mechanisms involved have not yet been fully elucidated. Aim To identify associations between 12 plasma cognition-related biomarkers and frailty in community-dwelling older adults. Methods A total of 375 participants (age 70.9 +/- 5.8, 165 men and 210 women) were included in this study. Frailty was assessed using the modified Fried frailty phenotype. Participants were divided into not-frail group (n = 313) and frail group (n = 62). Twelve plasma cognitive biomarkers were detected by enzyme-linked immunosorbent assay (ELISA). Multinomial logistic regression was used to explore the association between different biomarkers and frailty status. Results Among the 12 biomarkers, only pTau was higher in frail individuals than in their not-frail peers (471.3 +/- 58.1 pg/mL vs. 451.9 +/- 61.1 pg/mL, p = 0.022). No other biomarkers had any significant association with frailty, including total-Tau (tTau), neurofilament light (NFL), amyloid-beta 40 (A beta 40), amyloid-beta 40 (A beta 42), S100 calcium binding protein B (S100B), visinin-like protein 1 (VLP-1), Alzheimer-associated neuronal thread protein (AD7cNTP), beta-amyloid precursor protein (beta APP), chitinase-3-like-1 (CHI3L1), soluble complement receptor 1 (sCR1) and heart-type fatty acid binding protein (hFABP). Furthermore, pTau was compared between negative and positive subject groups for each individual criterion of frailty. Significantly higher levels of pTau were observed in those who were positive for the criteria of low grip strength (451.2 +/- 61.4 pg/mL vs. 469.1 +/- 57.6 pg/mL, p = 0.019), exhaustion (451.2 +/- 61.6 pg/mL vs. 466.4 +/- 58.4 pg/mL, p = 0.035) and low physical activity (451.1 +/- 60.7 pg/mL vs. 465.7 +/- 60.7 pg/mL, p = 0.034) when compared to those who were negative for each corresponding criterion. Finally, in the multivariable-adjusted analysis, the association between pTau and frailty was statistically significantly associated (OR: 1.40, 95% CI: 1.04-1.89), even after adjusting. Conclusions The present study found a potential association between pTau and frailty. Future works should monitor the longitudinal trajectory of changes of pTau concentrations in frailty older adults. A better understanding of the molecular mechanisms behind will contribute to biomarker research in frailty.